Using CEST-MRI tumor pH mapping in our PDAC model, we confirmed that L-DOS47 raises the pHe of acidic tumors, which contributes to the enhanced efficacy of anti-PD1 therapy in combination with L-DOS47. The gene discussed is PDCD1; the disease is neoplasm.